FoRx Therapeutics
@forxtherapeutics.com
Next-Generation Therapeutics FoRx Therapeutics is a privately held clinical-stage biotechnology company pioneering precision therapeutics targeting DNA Replication Stress in treatment-resistant cancers. FoRx is developing first- and best-in-class compounds for cancer treatment by focusing on drugging key molecular targets involved in DNA replication stress, a new approach towards the development of targeted anticancer drugs. Our team […]
FoRx Therapeutics's Company Logos
FoRx Therapeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#B81E38
Cardinal
184, 30, 56
350, 72, 42
0, 84, 70, 28
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#2A1B32
Bleached Cedar
42, 27, 50
279, 30, 15
16, 46, 0, 80
About FoRx Therapeutics
FoRx Therapeutics is a dynamic and innovative brand, dedicated to the development of groundbreaking compounds for the treatment of cancer. As a recently incorporated privately-held company, FoRx is at the forefront of the industry, aiming to revolutionize cancer treatment with its first-in-class compounds. The brand's unique approach focuses on drugging key molecular targets related to DNA replication stress, offering a new avenue in the development of targeted anticancer drugs.
With a team of experienced scientists and advisors boasting over 20 years of expertise in DNA replication stress and DNA Damage Response pathways, FoRx is well-equipped to deliver exceptional results. Based in Basel, Switzerland, a distinguished biotech and pharmaceutical hub, FoRx enjoys proximity to industry leaders. This strategic location allows for collaboration and access to cutting-edge advancements in the field.
Follow FoRx Therapeutics as they continue to make strides in the development of compounds against targets involved in the repair of collapsed DNA replication forks
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
2-10 employees
